Your browser doesn't support javascript.
loading
Hepato-splenic axis: hepatic and splenic metabolic activities are linked.
Keramida, Georgia; Dunford, Alexander; Kaya, Guven; Anagnostopoulos, Constantinos D; Peters, Adrien Michael.
Afiliación
  • Keramida G; Royal Brompton and Harefield NHS Trust London, UK.
  • Dunford A; Clinical Imaging Sciences Centre, Brighton Sussex Medical School Brighton, UK.
  • Kaya G; Brighton and Sussex University Hospitals NHS Trust Brighton, UK.
  • Anagnostopoulos CD; Brighton and Sussex University Hospitals NHS Trust Brighton, UK.
  • Peters AM; Center for Experimental Surgery, Clinical and Translational Research, Biomedical Research Foundation Academy of Athens Greece.
Am J Nucl Med Mol Imaging ; 8(3): 228-238, 2018.
Article en En | MEDLINE | ID: mdl-30042872
ABSTRACT
The concept of a hepato-splenic axis has recently been put forward. We aimed to investigate whether hepatic and splenic metabolic activities are linked, and if splenic metabolic activity is increased in non-alcoholic fatty liver disease (NAFLD). Blood clearance rates of phosphorylated 18F-fluorodeoxyglucose were measured in the spleen and liver from dynamic PET using Gjedde-Patlak-Rutland graphical analysis and abdominal aorta for input function in 59 patients undergoing routine PET/CT. Plot gradient (Ki), which represents blood clearance, was divided by intercept (V(0)), which represents tissue FDG distribution volume, and multiplied by blood glucose to give glucose uptake rate per unit tracer distribution volume (MRglu). In addition, liver-to-spleen raw count rate ratio was plotted against time, and gradient (b) divided by intercept (A) to obtain hepatic-to-splenic blood clearance ratio independent of aortic input function. Hepatic steatosis was inferred when hepatic CT density was ≤40 HU. There was no difference in splenic MRglu between 8 patients with inactive lympho-proliferative disease (LPD) as identified by negative PET/CT, 25 with non-haematological malignancy and 13 with normal PET/CT. It was significantly increased in 13 with active LPD, who were therefore excluded, along with 3 more with type-2 diabetes mellitus. Splenic MRglu was higher in patients with hepatic steatosis (4.0±1.6; n = 12) than without (2.6±1.7 µmol/min/100 ml; P = 0.02) and correlated inversely with hepatic CT density (r = -0.49; P<0.001). Hepatic and splenic Ki/V(0) correlated (r = 0.52; P<0.01) in 22 patients in whom the correlation coefficient between b/A and hepatic-to-splenic Ki/V(0) ratio was 0.99 and in whom, therefore, input function errors in graphical analysis could be discounted. In men, splenic longitudinal diameter correlated significantly with hepatic CT density (r = -0.35; P = 0.046), hepatic MRglu (r = 0.44; P = 0.005) and splenic MRglu (r = 0.35; P = 0.046). Splenic Ki/V(0) correlated positively with blood glucose, suggesting sensitivity to insulin. We conclude that hepatic and splenic metabolic activities are linked and that a speculative mechanism, which deserves further investigation, is shared insulin sensitivity. Splenic MRglu and spleen size are increased in NAFLD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Nucl Med Mol Imaging Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Nucl Med Mol Imaging Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
...